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A B S T R A C T
Background: There is presently no data to describe normal distribution of carotid intima-media thickness
(CIMT), an established measure of subclinical atherosclerosis, in Indian subjects.
Methods: In this multi-centric study, 1229 subjects with age 30 years and no previous cardiovascular
disease (CVD) underwent CVD risk factor assessment and CIMT measurement. Mean far wall common
carotid artery IMT was measured on both sides and averaged.
Results: Mean age of the subjects was 48.0  12.0 years and 54.2% were men. CIMT measurement was
feasible in 1157 subjects. Mean, median and 75th percentile values of CIMT for different age-groups were
derived for men and women separately. There was a progressive increase in CIMT with increasing age
(P < 0.001) and men had higher CIMT values than women (0.608  0.12 mm vs. 0.579  0.11 mm, P < 0.001).
The CIMT values were also higher in diabetics (0.635  0.10 mm) and hypertensives (0.624  0.10 mm) as
compared to non-diabetics (0.589  0.12 mm, P < 0.001) and non-hypertensives (0.592  0.12, P 0.02)
respectively. Among continuous variables, age, systolic blood pressure and fasting blood glucose had strong
to modest correlation with CIMT (Pearson’s r 0.524, 0.282 and 0.192 respectively, all P values <0.001),
whereas body mass index, diastolic blood pressure and serum triglycerides exhibited weak but still
statistically signiﬁcant relationship (Pearson’s r 0.069, P 0.019; Pearson’s r 0.065, P 0.026; and Pearson’s r
0.094, P 0.001, respectively).
Conclusions: This is the ﬁrst study to provide age- and gender-speciﬁc distribution of CIMT in Indian
subjects free from CVD. This information should help facilitate further research and clinical work
involving CIMT in India.
 2016 Cardiological Society of India. Published by Elsevier B.V. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Early detection of atherosclerosis, when still in its preclinical
stage, has emerged as a promising approach to facilitate optimum
cardiovascular disease (CVD) risk stratiﬁcation of asymptomatic
individuals.1–4 Although deﬁnitive outcome data is lacking,
preliminary evidence suggests that addition of atherosclerosis
imaging to conventional risk assessment tools may help better* Corresponding author at: Clinical and Preventive Cardiology, Medanta – The
Medicity, Sector 38, Gurgaon 122001, India. Tel.: +91 9971698148.
E-mail address: rrkasliwal@hotmail.com (R.R. Kasliwal).
1See Appendix A.
http://dx.doi.org/10.1016/j.ihj.2016.04.009
0019-4832/ 2016 Cardiological Society of India. Published by Elsevier B.V. This is an
licenses/by-nc-nd/4.0/).determine the nature and aggressiveness of the required preven-
tive measures and can thus improve clinical outcomes.5 In
addition, limited evidence also suggests that detection of
structural evidence of atherosclerosis may improve patient
compliance toward therapeutic measures.6–10
Numerous tools have been developed for preclinical atheroscle-
rosis assessment, such as carotid intima media thickness (CIMT),
coronary calcium score (CCS), brachial artery ﬂow-mediated
dilatation, pulse wave velocity, ankle brachial index, etc. Of these,
CIMT is one of the most extensively utilized modalities. A large
number of clinical trials involving several thousand patients have
shown that increased CIMT is associated with increased risk of
vascular events, independent of conventional CVD risk factors or open access article under the CC BY-NC-ND license (http://creativecommons.org/
Fig. 1. Longitudinal image of carotid bifurcation showing distal part of common
carotid artery, carotid bifurcation and the proximal segments of external and
internal carotid arteries. ‘Double lines’ of intima and adventitia are also seen at the
far wall of the common carotid artery. CCA, common carotid artery; ECA, external
carotid artery; ICA, internal carotid artery
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atherosclerosis imaging, CIMT has the advantages of being less
expensive, widely available and being free from ionizing radiation.
However, CIMT is signiﬁcantly inﬂuenced by ethnicity and
therefore ethnic-speciﬁc reference values are needed for inter-
preting CIMT values in a given individual. Although numerous
small scale studies have evaluated associations of CIMT in Indian
subjects,17–22 there is unfortunately no large-scale study to
provide normal values of CIMT in Indian subjects. Therefore, this
study was sought with the primary objective of deﬁning normal
distribution of CIMT in Indian subjects and to also explore the
relationship of CIMT values with various demographics character-
istics and CVD risk factors in Indians.
2. Methodology
2.1. Study design and procedure details
This was a non-interventional, observational, cross-sectional
study, conducted at 15 sites across India. The study was performed
in accordance with the ethical guidelines of the Declaration of
Helsinki. Institutional review board and the local ethics committee
approval was obtained at each site (the core ethics committee:
Medanta Independent Ethics Committee, study no. MICR-208/
2012). A written informed consent was obtained from all the
participants.
A total of 1229 asymptomatic subjects with age 30 years and
no pre-existing CVD were enrolled in the study. The subjects were
recruited from participating clinics/hospitals and included healthy
volunteers or those undergoing preventive health checks. The
absence of signiﬁcant coronary artery disease (CAD) was con-
ﬁrmed on the basis of history and normal exercise stress test. The
subjects were excluded if they (1) had any acute or chronic
systemic illness, (including gastro-intestinal, renal, hepatic, central
nervous system, respiratory, infectious, or psychiatric diseases), (2)
were already taking lipid lowering drug for more than three
months, (3) had known hypersensitivity to carotid bulb, (4) were
suffering from any medical condition that, in the opinion of the
investigator, would have interfered with safe completion of the
study, or (5) were already participating in any other clinical study.
In addition, pregnant or lactating women were also not allowed to
take part in this study. A urine pregnancy test was performed for all
female participants with child bearing potential to exclude
pregnancy.
Each site was encouraged to recruit subjects in an age-stratiﬁed
manner with nearly equal number of subjects in each of the
following four age groups:
 30–39 years,
 40–49 years,
 50–59 years, and
 60 years and above.
Once recruited in the study, all participants underwent clinical
assessment, biochemical investigations and CIMT measurement.
All the study procedures were completed in a single day. However,
due to any reason, if any study variable was not captured on the
same day, the subject was asked to come back for a second visit
within 7 days of the ﬁrst visit.
Clinical assessment included a detailed medical history about
CVD risk factors, concomitant medications and symptoms
suggestive of CVD, if any; height, weight and blood pressure
(BP) measurement; and examination of the cardiovascular system.
BP was measured in the right arm in supine position, using a
standard sphygmomanometer. Laboratory investigations included
fasting blood glucose and lipid proﬁle estimation; and estimationof spot urinary albumin concentration. For the purpose of the
present study, hypertension was deﬁned according to Joint
National Committee (JNC) 7 guidelines as systolic BP 140 mmHg
or diastolic BP 90 mmHg or previous history of hypertension or
self-reported use of anti-hypertensive medications.23 Diabetes
mellitus was deﬁned as fasting blood glucose 126 mg/dL or 2-
hour postprandial blood glucose 200 mg/dL or pharmacological
treatment for diabetes or previous history of diabetes mellitus.24
Family history was considered positive if a coronary event had
occurred in a male ﬁrst degree relative before the age of 55 years or
a female ﬁrst degree relative before the age of 65 years.25 Smoking
or tobacco use in any form during the preceding month was also
considered to be a CVD risk factor.
2.2. CIMT measurement
The measurement of CIMT was performed following the
recently published guidelines of the American Society of Echocar-
diography (ASE).4 The images were obtained at the participating
study sites and were then transferred to the core lab for ofﬂine
CIMT measurement.
2.2.1. Image acquisition
Imaging was performed using a linear-array transducer with
minimum fundamental frequency of 7 MHz attached to Sonosite
M-turbo 1.5 color Doppler ultrasound system.
The subjects were asked to lie supine with head resting
comfortably. The neck was slightly hyperextended and rotated in
the direction opposite to the side of measurement. ECG was
connected for obtaining R-wave gated images. The default scan
depth was kept at 4 cm but could be changed depending on the
built of the person. Common carotid artery (CCA) was imaged in
longitudinal plane and optimal angle of incidence was identiﬁed.
The optimal angle of incidence is deﬁned as the plane in which the
bifurcation of the carotid bulb into the internal and external
carotid arteries can be visualized simultaneously with the bulb and
distal CCA (Fig. 1). Once this view was created, ﬁner adjustments in
the transducer position were done to ensure that distal CCA was
perfectly horizontal on the screen and ‘double lines’ of intima and
adventitia were clearly visualized in the far wall of the CCA (Fig. 1).
After optimizing the image, a cine-loop with 3–5 beats was stored.
The CCA was then imaged from two additional complimentary
angles, approximately 458 anterior and posterior to the ﬁrst image
Fig. 2. Carotid intima media thickness measurement using the off-line analysis software.
Table 1
Clinical characteristics of the study population (n = 1229).
Parameter Value
Age (years) 48.0  12.0
Male gender, n (%) 666 (54.2)
Body mass index (kg/m2) 26.0  4.1
Hypertension, n (%) 96 (7.8)
Diabetes, n (%) 137 (11.1)
Smoking, n (%) 129 (10.5)
Family history of premature CAD, n (%) 121 (9.8)
Systolic BP (mmHg) 125  16
Diastolic BP (mmHg) 78  11
Fasting blood sugar (mg/dL) 104.9  37.8
Total cholesterol (mg/dL) 182.0  39.7
Serum triglycerides (mg/dL) 141.9  80.1
HDL-cholesterol (mg/dL) 43.6  12.1
LDL-cholesterol (mg/dL) 114.4  31.9
Urinary albumin concentration (mg/L) (n = 664) 37.3  56.9
All values are mean  standard deviation or actual number with percentages in
parenthesis.
BP, blood pressure; CAD, coronary artery disease; HDL, high-density lipoprotein; LDL,
low-density lipoprotein.
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transferred to a CD in DICOM format for ofﬂine analysis.
2.2.2. Image analysis
The image analysis was performed at the core lab, using the
semi-automated software provided by SonoSite Ltd. (Fig. 2). All
images were analyzed by a single observer. Only the far wall CIMT
of distal 1 cm of CCA was measured, as recommended by the ASE.4
For analysis, the images were transferred from the CD to the
workstation and were ﬁrst reviewed for overall image quality. Each
loop was then played individually and the R-wave gated still frame
showing the best image of distal 1 cm of CCA far wall was selected
for CIMT measurement.
A region-of-interest box with 1 cm length was placed at the
distal end of the CCA, just before bifurcation. The software then
automatically traced lumen-intima and media-adventitia inter-
faces using leading edge-to-leading edge method. Manual
adjustments were done to ensure optimum tracing. If a plaque
was present in the segment where CIMT measurement was
being performed, it was traced as part of CIMT. The software
then provided mean and maximum values of CIMT over 1 cm
length of CCA (Fig. 2), which were recorded. The same process
was then repeated for all the three angles on both sides. Thus, six
(three for each side) values of mean and maximum CIMT were
obtained for each subject. The six mean CIMT values were
averaged to provide composite ‘mean CIMT’ which was used for
subsequent analysis.
2.3. Statistical methods
The data were managed on Microsoft excel spreadsheet (version
2007, Microsoft Corp., Seattle, Washington) and analyzed using SPSS
for Windows (release 15.0, SPSS Inc., Chicago, IL, USA). Standard
descriptive analysis was performed to analyze the baseline
characteristics of the study population. Continuous values were
expressed as mean with standard deviation and the categorical
values as actual numbers with percentages. For obtaining CIMT
distribution, mean, median and 75th percentile values of mean CIMT
were derived for each age-group, for men and women separately.
For assessing the relationship between various CVD risk factors
and CIMT, Student’s independent samples t-test was used fordichotomous risk factors and Pearson’s correlation coefﬁcient
for continuous variables. Spearman’s rank correlation was used
for assessing the statistical signiﬁcance of CIMT trend across the
age-groups. Multiple regression analysis was used for determining
the relative strength of association between various CVD risk
factors and CIMT. A P value <0.05 was considered statistically
signiﬁcant for all the analysis performed.
2.3.1. Measurement variability
As mentioned above, all the CIMT measurements in the present
study were performed by a single observer. The same observer
repeated measurements in 20 randomly selected studies. Coefﬁ-
cient of variation was calculated and Bland–Altman plot con-
structed to assess the intra-observer variability.
3. Results
Table 1 summarizes the clinical characteristics of the study
population. Mean age of the study subjects was 48.0  12.0 years
and 54.2% (666 of 1229) were men. Of all the subjects, 11.1% were
Fig. 3. Age- and gender-wise distribution of mean carotid intima-media thickness in the study population. All values represent median values.
Table 2
Age- and gender-wise distribution of mean carotid intima-media thicknessa in the study population.
Age group Men (n = 624) Women (n = 533)
N Mean  SD Median 75th percentile N Mean  SD Median 75th percentile
30–39 years 186 0.528  0.06 0.522 0.561 153 0.510  0.06 0.503 0.543
40–49 years 170 0.583  0.08 0.573 0.623 138 0.577  0.11 0.555 0.605
50–59 years 149 0.642  0.13 0.619 0.686 129 0.609  0.09 0.593 0.651
60 years 119 0.725  0.14 0.697 0.771 113 0.641  0.11 0.623 0.682
a All values are in mm.
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9.8% had family history of premature CAD. Mean body mass index was
26.0  4.1 kg/m2.
3.1. CIMT distribution
Of the 1229 subjects, 1203 (98.0%) completed the study and
therefore had carotid scanning done. Of these 1203 subjects,
46 subjects (3.8%) had to be excluded because of the poor image
quality. Thus, CIMT measurement was performed in the remaining
1157 subjects (94.1% of total).
The ASE has recommended using age- and gender-speciﬁc 75th
percentile values of CIMT as the upper limits of normal.4
Accordingly, mean, median and 75th percentile values of meanTable 3
Age- and gender-wise distribution of mean carotid intima-media thicknessa in the stu
Age group Men (n = 624) 
N Mean  SD Median 75th percen
Subjects without diabetes (total 1023; men 542, women 481)
30–39 years 179 0.526  0.06 0.520 0.556 
40–49 years 150 0.582  0.08 0.575 0.621 
50–59 years 128 0.640  0.13 0.619 0.682 
60 years 85 0.732  0.16 0.697 0.771 
Subjects without diabetes and hypertension (total 973; men 511, women 462)
30–39 years 174 0.525  0.06 0.520 0.555 
40–49 years 143 0.582  0.08 0.574 0.622 
50–59 years 116 0.639  0.13 0.611 0.679 
60 years 78 0.732  0.16 0.680 0.771 
Subjects without diabetes, hypertension, smoking or family history of premature CAD (to
30–39 years 135 0.523  0.06 0.524 0.553 
40–49 years 99 0.582  0.08 0.577 0.626 
50–59 years 87 0.646  0.14 0.619 0.687 
60 years 60 0.737  0.15 0.706 0.791 
a All values are in mm.
CAD, coronary artery disease.CIMT for men and women in each age-group are provided in
Table 2. As is evident, there was progressive increase in CIMT with
increasing age (P < 0.001, Fig. 3) and men had higher CIMT values
than women in each age group (overall mean CIMT
0.608  0.12 mm in men vs. 0.579  0.11 mm in women, P < 0.001).
Table 3 summarizes age and gender speciﬁc CIMT values in
individuals without diabetes, those without diabetes and hyper-
tension and those without diabetes, hypertension, smoking and
family history of premature CAD.
3.2. Relationship between various CVD risk factors and CIMT (Table 4)
As already mentioned above, men had higher CIMT values
than women. The CIMT values were also higher in diabeticsdy population in absence of various cardiovascular risk factors.
Women (n = 533)
tile N Mean  SD Median 75th percentile
149 0.510  0.06 0.503 0.543
133 0.579  0.11 0.555 0.609
111 0.607  0.09 0.590 0.654
88 0.647  0.11 0.621 0.680
149 0.510  0.06 0.503 0.543
132 0.579  0.11 0.556 0.610
103 0.607  0.09 0.590 0.657
78 0.651  0.17 0.622 0.680
tal 798; men 381, women 417)
135 0.507  0.06 0.503 0.541
115 0.576  0.11 0.553 0.599
94 0.607  0.10 0.590 0.658
73 0.654  0.12 0.618 0.686
Fig. 4. Bland–Altman limits of agreement for intra-observer reproducibility of
carotid intima media thickness measurement in the present study.
Table 4
Relationship between mean carotid intima-media thickness and various cardio-
vascular risk factors.
Categorical variables
Variable Statistics
Mean CIMT (mm)* P value**
Risk factor absent Risk factor present
Male gender 0.579  0.11 0.608  0.12 <0.001
Hypertension 0.592  0.12 0.624  0.10 0.02
Diabetes 0.589  0.12 0.635  0.10 <0.001
Smoking 0.594  0.12 0.603  0.12 0.38
Family history
of premature CAD
0.596  0.12 0.582  0.09 0.282
Continuous variables
Variable Statistics
Correlation coefﬁcient P value
Age 0.524 <0.001
Body mass index 0.069 0.019
Systolic BP 0.282 <0.001
Diastolic BP 0.065 0.026
Fasting blood sugar 0.192 <0.001
Total cholesterol 0.037 0.21
Serum triglycerides 0.094 0.001
HDL-cholesterol <0.005 0.992
LDL-cholesterol 0.002 0.951
Urinary albumin
concentration
0.127 <0.001
* Values are mean  standard deviation.
** P values derived using Student’s independent samples t-test.
BP, blood pressure; CAD, coronary artery disease; CIMT, carotid intima-media
thickness; HDL, high-density lipoprotein; LDL, low-density lipoprotein.
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pared to non-diabetics (0.589  0.12 mm, P < 0.001) and non-
hypertensives (0.592  0.12 mm, P 0.02) respectively. However,
family history of premature CAD and smoking did not demonstrate
any signiﬁcant relationship with CIMT. Among continuous variables,
age, systolic BP and fasting blood glucose had strong to modest
correlation with CIMT (Pearson’s r 0.524, 0.282 and 0.192 respectively,
all P values <0.001), whereas body mass index, diastolic BP, serum
triglycerides and urinary albumin concentration exhibited weak but
still statistically signiﬁcant relationship (Pearson’s r 0.069, P 0.019;
Pearson’s r 0.065, P 0.026; Pearson’s r 0.094, P 0.001; and Pearson’s r
0.127, P < 0.001, respectively) (Table 4). On multivariate analysis, age
and gender demonstrated strongest association with CIMT among the
risk factors included in the analysis (Table 5).Table 5
Multivariate regression analysis to assess determinants of carotid intima-media
thickness.
Unstandardized
coefﬁcients
Standardized
coefﬁcients
t P value
B Std. Error Beta
(Constant) 0.259 0.030 8.59 <0.001
Age (years) 0.004 <0.005 0.502 14.57 <0.001
Male gender 0.033 0.007 0.166 5.03 <0.001
Body mass index
(kg/m2)
0.002 0.001 0.068 2.044 0.041
Systolic blood
pressure
(mmHg)
<0.001 <0.001 0.046 1.302 0.194
Fasting blood
glucose
(mmHg)
<0.005 <0.005 0.135 4.041 <0.001
Urinary albumin
concentration
(mg/L)
<0.001 <0.001 0.003 0.101 0.9203.3. Intra-observer variability
Fig. 4 depicts Bland–Altman limits of agreement for intra-
observer reproducibility of mean CIMT. The average difference
between repeat measurements was 0.011 mm with standard
deviation 0.032 mm and coefﬁcient of variation 5.2%. These values
are consistent with those previously reported in the literature.26–28
4. Discussion
The rapid increase in the prevalence of CVD world over has
necessitated development of aggressive strategies for its preven-
tion. One of the key requirements for any CVD preventive strategy
to be effective is the ability to accurately identify the individuals
who are at high risk of developing CVD. Focusing on these ‘high
risk’ individuals is expected to result in the most effective
utilization of the limited healthcare resources. Additionally, the
knowledge of the anticipated CVD risk may also help improve
patients’ health-related behaviors and improve the compliance to
the treatment.
Traditionally, assessment of the CVD risk is performed by taking
in to consideration the presence or absence of various CVD risk
factors and subsequently using one of the several risk algorithms
currently available.25 A major limitation with these risk algorithms
is that they only provide probabilities of developing a CVD event
but cannot identify the individuals who are actually going to
develop the disease. Thus, while these algorithms work well at the
population level, their accuracy at the individual level is
suboptimal. To overcome this limitation, detection of subclinical
atherosclerosis has been proposed as an alternate strategy with the
premise that the presence of an early evidence of atherosclerosis in
a given individual will conﬁrm his/her susceptibility to develop
atherosclerosis regardless of the presence or absence of various
CVD risk factors.
A number of tools for detection of subclinical atherosclerosis
are now available, such as carotid ultrasound imaging for CIMT
and carotid plaque assessment, CCS, brachial artery ﬂow-
mediated dilatation, pulse wave velocity, ankle brachial index,
etc. Of these, CCS and CIMT are the most extensively utilized
modalities and a large number of studies have documented their
incremental value in predicting CVD risk over conventional risk
factors.1,4,11–16,29–34 Although CIMT has relatively less robust
evidence base as compared to CCS, it has the advantages of being
less expensive, widely available, simpler to perform, and the most
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make CIMT an attractive option for incorporation in to routine
clinical practice. Although various authorities have provided
different recommendations for clinical use of CIMT,1,35,36 it is
already being increasingly adopted for CVD risk stratiﬁcation in
clinical practice.
However, a major challenge with CIMT, just as with all other
atherosclerosis imaging modalities, is that it varies with age,
gender and ethnicity. Accordingly, ethnic-speciﬁc normative data
needs to be used for interpreting CIMT results in a given
population. Unfortunately, while a number of studies have
evaluated the association of CIMT with CVD risk factors and
prevalent CVD in Indian subjects,17–22 no large-scale study has so
far provided normal distribution of CIMT in this population. This
has remained a major factor limiting wider use of CIMT in clinical
practice in India. The present study was conducted as an attempt to
ﬁll this knowledge gap. Using a fairly large study sample of men
and women free from existing CVD, we derived age- and gender-
speciﬁc normative data for CIMT in Indians.
While deriving normative data, most of the previous large
studies had included all subjects, regardless of the presence or
absence of CVD risk factors,11,12,15,34 and therefore we have also
followed the same approach. The reason for not excluding
individuals with CVD factors is that the actual incremental value
of CIMT is only when it is added to conventional CVD risk
factors. As is well established, and was observed in our study
too, CIMT values are much lower in individuals who are
completely free from all major CVD risk factors. Using these
values as reference will result in most of the subjects with one
or more CVD risk factors being considered to have increased
CIMT, thus defeating the very purpose of risk stratiﬁcation.
Nevertheless, for the beneﬁt of the readers, we have also
provided CIMT values in individuals who were free from various
speciﬁc CVD risk factors.
It is noteworthy that in our study we found signiﬁcant
relationship of CIMT with various CVD risk factors such as age,
gender, diabetes, hypertension, urine albumin concentration etc.
These ﬁndings are consistent with the existing literature on CIMT
and provide an indirect validation of our data.
4.1. Limitations
Our study had certain limitations that merit attention. Although
this is the largest study to describe normal distribution of CIMT in
Indians, it is still small given the overall size and the diversity of our
population. For this reason, the present study ﬁndings cannot be
described as true normative values of CIMT in India. Nevertheless,
our study still is an important step toward ﬁlling this huge
knowledge gap and should be of help in future research and clinical
work in India, until larger data is generated.
Second, due to logistic reasons, we did not speciﬁcally look for
carotid plaques in this study. Previous studies have shown that
carotid plaques have stronger association with the presence of
obstructive CAD and the future CVD risk as compared to CIMT37–40
and therefore, detection of carotid plaques (along with CIMT
measurement) forms a part of carotid ultrasound examination for
CVD risk stratiﬁcation. However, it should be noted that in
apparently healthy young individuals carotid plaques are seen in
only <10% subjects.38 Thus, while the presence of a carotid plaque
signiﬁes high CVD risk, absence of a plaque does not help clinicians
in assessing CVD risk. For this reason, we believe, lack of
information about carotid plaques is unlikely to have appreciably
affected the signiﬁcance of our ﬁndings. Moreover, the primary
purpose of the present study was to describe distribution of CIMT
and not to evaluate the comparative predictive accuracy of CIMT
and carotid plaques. This was also the reason (coupled with logisticchallenges) why we did not look for other novel CVD risk factors
and other measures of subclinical atherosclerosis in this study.
5. Conclusions
To the best of our knowledge, this is the ﬁrst large-scale study to
provide age- and gender-speciﬁc distribution of CIMT in Indian
subjects free from pre-existing CVD. This information should help
facilitate further research and clinical work involving CIMT in India.
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